• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者生前腰椎脑脊液、血清及死后脑室中免疫反应性载脂蛋白E的情况

Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.

作者信息

Rösler N, Wichart I, Jellinger K A

机构信息

Ludwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, Vienna, Austria.

出版信息

J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):452-4. doi: 10.1136/jnnp.60.4.452.

DOI:10.1136/jnnp.60.4.452
PMID:8774418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1073906/
Abstract

Using a specific enzyme linked immunosorbent assay (ELISA) method, total apolipoprotein E immunoreactivity (tApoE-IR) was measured in premortem lumbar CSF and serum of patients with "probable" Alzheimer's disease and in postmortem ventricular CSF of patients with Alzheimer's disease confirmed by necropsy. Concentrations were compared with those from patients with other neurological diseases and controls. The mean serum:lumbar CSF ratio of ApoE-IR was 15.9 suggesting that the main portion of lumbar ApoE-IR is synthesised intrathecally. No significant differences in ApoE-IR between patients with Alzheimer's disease and the other groups were detected in either CSF compartment. In lumbar CSF, there was no correlation between ApoE-IR of patients with Alzheimer's disease and their mini mental state scores. These results suggest that the diagnostic value of ApoE-IR measurements in CSF of patients with Alzheimer's disease as a single determination is less than that of other markers, in particular tau protein. On the other hand, ApoE determinations could be useful as part of a neurochemical profile of Alzheimer's disease.

摘要

采用特定的酶联免疫吸附测定(ELISA)方法,对“可能”患有阿尔茨海默病患者生前的腰椎脑脊液和血清以及经尸检确诊为阿尔茨海默病患者死后的脑室脑脊液中的总载脂蛋白E免疫反应性(tApoE-IR)进行了测量。将这些浓度与患有其他神经系统疾病的患者及对照组的浓度进行了比较。ApoE-IR的血清与腰椎脑脊液平均比值为15.9,表明腰椎ApoE-IR的主要部分是在鞘内合成的。在任何一个脑脊液腔室中,均未检测到阿尔茨海默病患者与其他组之间ApoE-IR存在显著差异。在腰椎脑脊液中,阿尔茨海默病患者的ApoE-IR与其简易精神状态评分之间无相关性。这些结果表明,作为单一测定指标,ApoE-IR测量在阿尔茨海默病患者脑脊液中的诊断价值低于其他标志物,尤其是tau蛋白。另一方面,ApoE测定作为阿尔茨海默病神经化学特征的一部分可能会有用。

相似文献

1
Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.阿尔茨海默病患者生前腰椎脑脊液、血清及死后脑室中免疫反应性载脂蛋白E的情况
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):452-4. doi: 10.1136/jnnp.60.4.452.
2
Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?
J Neural Transm Suppl. 1996;47:259-66. doi: 10.1007/978-3-7091-6892-9_18.
3
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.阿尔茨海默病患者脑脊液中前蛋白转化酶枯草溶菌素9(PCSK9)浓度升高。
J Alzheimers Dis. 2017;55(1):315-320. doi: 10.3233/JAD-160411.
4
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.阿尔茨海默病患者和对照者脑脊液和血浆中的总载脂蛋白 E 水平及特定同工型组成。
Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15.
5
Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients.阿尔茨海默病患者生前腰椎及死后脑室脑脊液中白细胞介素-6免疫反应性
Acta Neurol Scand. 2001 Feb;103(2):126-30. doi: 10.1034/j.1600-0404.2001.103002126.x.
6
Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.对照受试者脑脊液中载脂蛋白E水平随年龄下降,而阿尔茨海默病患者脑脊液中该水平升高。
Eur Neurol. 2000;43(3):161-9. doi: 10.1159/000008157.
7
Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.阿尔茨海默病中载脂蛋白E的基线脑脊液/血清比率及差异下降率
J Alzheimers Dis. 2015;48(1):189-96. doi: 10.3233/JAD-150286.
8
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
Neurochem Res. 2000 Apr;25(4):511-7. doi: 10.1023/a:1007516210548.
9
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.脑脊液tau蛋白作为阿尔茨海默病的生化标志物:一项基于社区的随访研究。
J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):298-305. doi: 10.1136/jnnp.64.3.298.
10
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.阿尔茨海默病患者脑脊液中载脂蛋白A-I浓度降低
J Alzheimers Dis. 2017;59(3):1017-1026. doi: 10.3233/JAD-170226.

引用本文的文献

1
Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.阿尔茨海默病患者腰椎脑脊液神经生化指标的临床意义
J Neural Transm (Vienna). 2001;108(2):231-46. doi: 10.1007/s007020170091.
2
Central nervous system lipoproteins in Alzheimer's disease.阿尔茨海默病中的中枢神经系统脂蛋白
Am J Pathol. 1997 Dec;151(6):1571-5.

本文引用的文献

1
Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease.阿尔茨海默病患者腰椎脑脊液中的总tau蛋白免疫反应性。
J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):237-8. doi: 10.1136/jnnp.60.2.237-a.
2
Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.载脂蛋白E:与可溶性阿尔茨海默病β-淀粉样蛋白的结合
Biochem Biophys Res Commun. 1993 Apr 30;192(2):359-65. doi: 10.1006/bbrc.1993.1423.
3
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.载脂蛋白E:与β-淀粉样蛋白的高亲和力结合及晚发性家族性阿尔茨海默病中4型等位基因频率增加
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81. doi: 10.1073/pnas.90.5.1977.
4
Clinical-neuropathological correlations in Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症的临床神经病理学相关性
Arch Neurol. 1994 Sep;51(9):888-95. doi: 10.1001/archneur.1994.00540210060013.
5
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.阿尔茨海默病患者脑脊液中的载脂蛋白E含量降低。
Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032.
6
Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease--correlation with degree of cognitive impairment.阿尔茨海默病患者脑脊液中tau蛋白水平升高——与认知障碍程度的相关性
Ann Neurol. 1995 Mar;37(3):414-5. doi: 10.1002/ana.410370325.
7
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
Trends Neurosci. 1994 Dec;17(12):525-30. doi: 10.1016/0166-2236(94)90156-2.
8
The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.美国国立神经疾病与中风研究所-阿尔茨海默病及相关疾病协会(NINCDS-ADRDA)工作组关于可能的阿尔茨海默病临床诊断的标准:57例临床病理研究
Neurology. 1988 Mar;38(3):359-64. doi: 10.1212/wnl.38.3.359.
9
Diagnosis of Alzheimer's disease.阿尔茨海默病的诊断
Arch Neurol. 1985 Nov;42(11):1097-105. doi: 10.1001/archneur.1985.04060100083029.
10
Clinicopathological analysis of dementia disorders in the elderly.
J Neurol Sci. 1990 Mar;95(3):239-58. doi: 10.1016/0022-510x(90)90072-u.